Durvalumab as a maintenance therapy after a definitive chemoradiotherapy for a stage III non-small cell lung cancer - an interim analysis of the PACIFIC trial

被引：0
|
作者：
Kawecki, Maciej [1 ]
机构：
[1] Maria Sklodowska Curie Inst Oncol, Dept Radiotherapy & Oncol, Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2018年 / 14卷 / 03期
关键词：
D O I：
10.5603/OCP.2018.0023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：167 / 170
页数：4
相关论文
共 50 条
  • [41] International Cost-Effectiveness Analysis of Durvalumab in Stage III Non-Small Cell Lung Cancer
    Kareff, Samuel A.
    Han, Sunwoo
    Haaland, Benjamin
    Jani, Chinmay J.
    Kohli, Rhea
    Aguiar Jr, Pedro Nazareth
    Huang, Yiqing
    Soo, Ross A.
    Rodriguez-Perez, Angel
    Garcia-Foncillas, Jesus
    Domine, Manuel
    de Lima Lopes, Gilberto
    JAMA NETWORK OPEN, 2024, 7 (05) : E2413938
  • [42] Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer
    Dickhoff, C.
    Unal, S.
    Heineman, D. J.
    Winkelman, J. A.
    Braun, J.
    Bahce, I.
    van Dorp, M.
    Senan, S.
    Dahele, M.
    LUNG CANCER, 2023, 182
  • [43] Prospective evaluation of outcome and toxicity of durvalumab treatment after chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC) patients
    Kaesmann, Lukas
    Taugner, Julian
    Eze, Chukwuka
    Roengvoraphoj, Olarn
    Belka, Claus
    Manapov, Farkhad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [44] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy
    Oh, H. -J.
    Park, C. -K.
    Kim, Y. -C.
    Kim, Y. -H.
    Ahn, S. -J.
    Jeong, W. G.
    Lee, J. Y.
    Lee, J. C.
    Choi, C. M.
    Ji, W.
    Song, S. Y.
    Choi, J.
    Lee, S. Y.
    Kim, H.
    Lee, S. Y.
    Park, J.
    Yoon, S. H.
    Joo, J. H.
    Oh, I. -J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S294 - S295
  • [45] Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer
    Kishi, Noriko
    Matsuo, Yukinori
    Shintani, Takashi
    Ogura, Masakazu
    Mitsuyoshi, Takamasa
    Araki, Norio
    Fujii, Kota
    Okumura, Setsuko
    Nakamatsu, Kiyoshi
    Kishi, Takahiro
    Atsuta, Tomoko
    Sakamoto, Takashi
    Ohtsu, Shuji
    Katagiri, Tomohiro
    Narabayashi, Masaru
    Fujishiro, Satsuki
    Iizuka, Yusuke
    Ozasa, Hiroaki
    Hirai, Toyohiro
    Mizowaki, Takashi
    JOURNAL OF RADIATION RESEARCH, 2023, 64 (01) : 142 - 153
  • [46] Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small cell lung cancer: a case report
    Zhang, Tao
    Wu, Yuqi
    Zheng, Shan
    Cheng, Guowei
    He, Xiangling
    Bi, Nan
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (04) : 2375 - 2380
  • [47] Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer
    Hamada, Akira
    Soh, Junichi
    Mitsudomi, Tetsuya
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 555 - 562
  • [48] Asthma caused by durvalumab after chemoradiotherapy in two patients with non-small cell lung cancer
    Uemura, Takehiro
    Fukumitsu, Kensuke
    Maeno, Ken
    Fukuda, Satoshi
    Onuki, Tomohiro
    Kanemitsu, Yoshihiro
    Oguri, Tetsuya
    Niimi, Akio
    Hida, Toyoaki
    RESPIROLOGY CASE REPORTS, 2021, 9 (09):
  • [49] Heterogeneity score in inoperable stage III non-small cell lung cancer patients treated with definitive chemoradiotherapy: A single centre analysis
    Taugner, J.
    Kaesmann, L.
    Eze, C.
    Dantes, M.
    Roengvoraphoj, O.
    Gennen, K.
    Karin, M.
    Tufman, A.
    Belka, C.
    Manapov, F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] Major Cardiovascular Events after Chemoradiotherapy with or without Durvalumab in Patients with Stage Ill Non-Small Cell Lung Cancer: Supplementary Analysis
    Kokubo, M.
    Kishi, N.
    Matsuo, Y.
    Ogura, M.
    Araki, N.
    Fujii, K.
    Okumura, S.
    Nakamatsu, K.
    Kishi, T.
    Atsuta, T.
    Sakamoto, T.
    Otsu, S.
    Katagiri, T.
    Narabayashi, M.
    Fujishiro, S.
    Iizuka, Y.
    Ozasa, H.
    Hirai, T.
    Mizowaki, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E30 - E31
12345